Akoya Biosciences Inc (AKYA)
3.97
+0.02
(+0.51%)
USD |
NASDAQ |
May 02, 13:27
Akoya Biosciences Cash from Operations (Quarterly): -5.584M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.584M |
| September 30, 2023 | -13.75M |
| June 30, 2023 | -11.80M |
| March 31, 2023 | -19.76M |
| December 31, 2022 | -10.01M |
| September 30, 2022 | -12.17M |
| June 30, 2022 | -13.39M |
| March 31, 2022 | -17.93M |
| Date | Value |
|---|---|
| December 31, 2021 | -5.854M |
| September 30, 2021 | -13.40M |
| June 30, 2021 | -12.42M |
| March 31, 2021 | -4.404M |
| December 31, 2020 | -2.147M |
| September 30, 2020 | -1.74M |
| June 30, 2020 | -1.999M |
| March 31, 2020 | -0.957M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-19.76M
Minimum
Mar 2023
-0.957M
Maximum
Mar 2020
-9.207M
Average
-10.91M
Median
Cash from Operations (Quarterly) Benchmarks
| Bruker Corp | 205.50M |
| Azenta Inc | 26.43M |
| Harvard Bioscience Inc | 4.303M |
| Bionano Genomics Inc | -29.78M |
| Singular Genomics Systems Inc | -18.90M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.594M |
| Cash from Financing (Quarterly) | 11.08M |
| Free Cash Flow | -54.55M |
| Free Cash Flow Per Share (Quarterly) | -0.1244 |
| Free Cash Flow to Equity (Quarterly) | -17.61M |
| Free Cash Flow to Firm (Quarterly) | -4.801M |
| Free Cash Flow Yield | -30.94% |